Sandoz Group AG | Finanzwire

BRIEF

published on 01/12/2026 at 15:05, 3 months 9 days ago

Sandoz Unveils Strategy for 'Golden Decade' of Affordable Medicines

Market Strategy Biosimilars Sandoz Group AG Golden Decade Affordable Medicines
PRESS RELEASE

published on 01/12/2026 at 15:00, 3 months 9 days ago

Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
Sandoz CEO to outline plans for capturing the unprecedented 'golden decade' of affordable medicines opportunity at the 44th Annual J.P. Morgan Healthcare Conference

CEO Sandoz J.P. Morgan Healthcare Conference Golden Decade Affordable Medicines
BRIEF

published on 12/08/2025 at 07:05, 4 months 14 days ago

Sandoz Acquires Just-Evotec Biologics EU SAS to Boost Biosimilar Leadership

Acquisition Healthcare Biosimilars Sandoz Group AG Continuous Manufacturing
PRESS RELEASE

published on 12/08/2025 at 07:00, 4 months 14 days ago

Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology

Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
BRIEF

published on 12/01/2025 at 07:05, 4 months 21 days ago

Sandoz Launches Denosumab Biosimilars in Europe

Bone Health Sandoz Denosumab Biosimilars Wyost® Jubbonti®
PRESS RELEASE

published on 12/01/2025 at 07:00, 4 months 21 days ago

Sandoz launches denosumab biosimilars in Europe, providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients
Sandoz launches denosumab biosimilars in Europe, providing affordable treatment options for cancer-related bone disease and osteoporosis. The European launch marks a key milestone in Sandoz's growth strategy

Europe Biosimilars Cancer Osteoporosis Sandoz
BRIEF

published on 11/24/2025 at 07:05, 4 months 28 days ago

Sandoz Launches Afqlir® in Europe for Retinal Diseases

Biosimilars Retinal Diseases Sandoz Europe Launch Afqlir®
PRESS RELEASE

published on 11/24/2025 at 07:00, 4 months 28 days ago

Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases
Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases. Afqlir® matches reference medicine in efficacy, safety, and pharmacokinetics, reinforcing Sandoz commitment to patient access

Retinal Diseases Sandoz Aflibercept Afqlir European Launch
BRIEF

published on 11/17/2025 at 07:05, 5 months 5 days ago

Sandoz Launches First MS Biosimilar TYRUKO® in US

Multiple Sclerosis Biosimilar Sandoz TYRUKO® Natalizumab
PRESS RELEASE

published on 11/17/2025 at 07:00, 5 months 5 days ago

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri®

US Market Multiple Sclerosis Biosimilar Sandoz TYRUKO

Published on 04/22/2026 at 13:45, 1 hour 3 minutes ago

Amarc Announces Listing on Frankfurt Stock Exchange
Published on 04/22/2026 at 13:30, 1 hour 18 minutes ago

ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:30, 1 hour 18 minutes ago

Copper Road Announces Engagement of George Mannard
Published on 04/22/2026 at 13:00, 1 hour 48 minutes ago

AmeriTrust Announces 2025 Annual Financial Results
Published on 04/22/2026 at 13:00, 1 hour 48 minutes ago

Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji

View all ACCESSWIRE

Published on 04/22/2026 at 14:35, 13 minutes ago

Infinite Launches Dedicated Bank Accounts for Embedded Stablecoin and Fiat Payments
Published on 04/22/2026 at 13:55, 52 minutes ago

EQS-Adhoc: Deutsche Rohstoff AG: Consolidated Financial Statements, Dividend Proposal and Guidance
Published on 04/22/2026 at 13:55, 53 minutes ago

Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone
Published on 04/22/2026 at 13:40, 1 hour 7 minutes ago

EQS-Adhoc: Rejection of appeal against the revocation of the admission of ZhongDe Waste Technology AG shares to trading on the regulated market (General Standard)
Published on 04/22/2026 at 13:35, 1 hour 13 minutes ago

DeFi Technologies' Asset Management Business, Valour, Secures US$11 Million in Institutional Investment into Hedera ETPs, Including US$10 Million on Börse Frankfurt and US$1 Million on Sweden's Spotlight

View all EQS

Published on 04/22/2026 at 07:00, 7 hours 48 minutes ago

Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/22/2026 at 06:55, 7 hours 53 minutes ago

Two Seasons In One Quarter
Published on 04/21/2026 at 19:15, 19 hours 33 minutes ago

AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 18:00, 20 hours 48 minutes ago

Outstanding shares and voting rights statement at 31 March 2026
Published on 04/21/2026 at 17:49, 20 hours 58 minutes ago

Solocal - Q1 2026 Revenue and Activity

View all LES ECHOS COMFI WIRE

News